1-11 of 11
John P. Leonard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors

Timothy A. Yap, Jane N. Winter, Lisa Giulino-Roth, Jemma Longley, Juanita Lopez, Jean-Marie Michot, John P. Leonard, Vincent Ribrag, Michael T. McCabe, Caretha L. Creasy, Melissa Stern, Teodora Pene Dumitrescu, Xiaowei Wang, Steve Frey, Jennifer Carver, Thierry Horner, Choon Oh, Ahmed Khaled, Arindam Dhar, Peter W.M. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (24): 7331–7339.
DOI: https://doi.org/10.1158/1078-0432.CCR-18-4121
Published: 13 December 2019
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract A11: Therapeutic targeting of GCB- and ABC-DLBCLS by rationally designed BCL6 inhibitors

Mariano Gonzalo Cardenas, Wenbo Yu, Wendy Beguelin, Teater R. Matthew, Huimin Geng, Rebecca Goldstein, Erin Oswald, Katerina Hatzi, Shao-Ning Yang, Joanna Cohen, Rita Shaknovich, Kenno Vanommeslaeghe, Huimin Cheng, Dongdong Liang, Hyoje Cho, Joshua Abbott, Wayne Tam, John P. Leonard, Leandro Cerchietti, Tomasz Cierpicki, Fengtian Xue, Alexander D. MacKerell, Jr., Ari Melnick
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (1_Supplement): A11.
DOI: https://doi.org/10.1158/1557-3265.PMCCAVULN16-A11
Published: 02 January 2017
View article
Journal Articles

Activities of SYK and PLCγ2 Predict Apoptotic Response of CLL Cells to SRC Tyrosine Kinase Inhibitor Dasatinib

Zibo Song, Pin Lu, Richard R. Furman, John P. Leonard, Peter Martin, Lauren Tyrell, Francis Y. Lee, Daniel M. Knowles, Morton Coleman, Y. Lynn Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (2): 587–599.
DOI: https://doi.org/10.1158/1078-0432.CCR-09-1519
Published: 14 January 2010
View article
PDF
Journal Articles

Epratuzumab: Targeting B-Cell Malignancies through CD22

Morton Coleman, David M. Goldenberg, Abby B. Siegel, Jamie C. Ketas, Michelle Ashe, Jennifer M. Fiore, John P. Leonard
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3991s–3994s.
Published: 31 August 2009
View article
Journal Articles

Epratuzumab, a Humanized Monoclonal Antibody Targeting CD22: Characterization of in Vitro Properties

Josette Carnahan, Paul Wang, Richard Kendall, Ching Chen, Sylvia Hu, Tom Boone, Todd Juan, Jane Talvenheimo, Silvia Montestruque, Jilin Sun, Gary Elliott, John Thomas, John Ferbas, Brent Kern, Robert Briddell, John P. Leonard, Alessandra Cesano
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3982s–3990s.
Published: 31 August 2009
View article
Journal Articles

Phase I Trial of Toll-Like Receptor 9 Agonist PF-3512676 with and Following Rituximab in Patients with Recurrent Indolent and Aggressive Non–Hodgkin's Lymphoma

John P. Leonard, Brian K. Link, Christos Emmanouilides, Stephanie A. Gregory, Daniel Weisdorf, Jeffrey Andrey, John Hainsworth, Joseph A. Sparano, Donald E. Tsai, Sandra Horning, Arthur M. Krieg, George J. Weiner
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (20): 6168–6174.
DOI: https://doi.org/10.1158/1078-0432.CCR-07-0815
Published: 18 October 2007
View article
PDF
Journal Articles

Phase I to III Trials of Anti–B Cell Therapy in Non–Hodgkin's Lymphoma

Peter Martin, Richard R. Furman, Morton Coleman, John P. Leonard
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5636s–5642s.
DOI: https://doi.org/10.1158/1078-0432.CCR-07-1085
Published: 17 September 2007
View article
PDF
Journal Articles

A Phase 2 Study of Rituximab in Combination with Recombinant Interleukin-2 for Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma

Khuda D. Khan, Christos Emmanouilides, Don M. Benson, Jr., Deborah Hurst, Pablo Garcia, Glenn Michelson, Sandra Milan, Amy K. Ferketich, Lawrence Piro, John P. Leonard, Pierluigi Porcu, Charles F. Eisenbeis, Amy L. Banks, Lei Chen, John C. Byrd, Michael A. Caligiuri
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (23): 7046–7053.
DOI: https://doi.org/10.1158/1078-0432.CCR-06-1571
Published: 04 December 2006
View article
PDF
Journal Articles

Magnitude of Stromal Hemangiogenesis Correlates with Histologic Subtype of Non–Hodgkin's Lymphoma

Jia Ruan, Elizabeth Hyjek, Pouneh Kermani, Paul J. Christos, Andrea T. Hooper, Morton Coleman, Barbara Hempstead, John P. Leonard, Amy Chadburn, Shahin Rafii
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (19): 5622–5631.
DOI: https://doi.org/10.1158/1078-0432.CCR-06-1204
Published: 04 October 2006
View article
PDF
Journal Articles

The Radioisotope Contributes Significantly to the Activity of Radioimmunotherapy

Thomas A. Davis, Mark S. Kaminski, John P. Leonard, Frank J. Hsu, Mary Wilkinson, Andrew Zelenetz, Richard L. Wahl, Stewart Kroll, Morton Coleman, Michael Goris, Ronald Levy, Susan J. Knox
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (23): 7792–7798.
DOI: https://doi.org/10.1158/1078-0432.CCR-04-0756
Published: 07 December 2004
View article
PDF
Journal Articles

Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma: Phase I/II Clinical Trial Results

John P. Leonard, Morton Coleman, Jamie C. Ketas, Amy Chadburn, Richard Furman, Michael W. Schuster, Eric J. Feldman, Michelle Ashe, Stephen J. Schuster, William A. Wegener, Hans J. Hansen, Heather Ziccardi, Michael Eschenberg, Urte Gayko, Scott Z. Fields, Alessandra Cesano, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (16): 5327–5334.
DOI: https://doi.org/10.1158/1078-0432.CCR-04-0294
Published: 24 August 2004
View article
PDF